Predicting the outcome of ankylosing spondylitis therapy

Predicting the outcome of ankylosing spondylitis therapy

Objectives To create a model that provides a potential basis for candidate selection for anti-tumour necrosis factor (TNF) treatment by predicting future outcomes relative to the current disease profile of individual patients with ankylosing spondylitis (AS). Methods ASSERT and GO–RAISE trial data (...

保存先:

書誌詳細
主要な著者:	Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U. Rahman, Ben A. C. Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes‐Estévez, Joachim Sieper, Jürgen Braun
フォーマット:	Artigo
言語:	英語
出版事項:	2011
オンライン･アクセス:	https://doi.org/10.1136/ard.2010.147744 https://ard.bmj.com/content/annrheumdis/70/6/973.full.pdf
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Predicting the outcome of ankylosing spondylitis therapy
著者:: Vastesaeger, Nathan, 等
出版事項: (2011)

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery
著者:: Bert Vander Cruyssen, 等
出版事項: (2009)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
著者:: van der Heijde, Désirée, 等
出版事項: (2019)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
著者:: Désirée van der Heijde, 等
出版事項: (2018)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
著者:: Braun, Jürgen, 等
出版事項: (2011)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
著者:: Jürgen Braun, 等
出版事項: (2011)

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
著者:: Wagner, Carrie, 等
出版事項: (2011)

Ankylosing spondylitis: an overview
著者:: Joachim Sieper, 等
出版事項: (2002)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
著者:: Deodhar, Atul, 等
出版事項: (2015)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
著者:: Atul Deodhar, 等
出版事項: (2014)

Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience
著者:: Braun, J, 等
出版事項: (2002)

The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
著者:: Désirée van der Heijde, 等
出版事項: (2014)

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
著者:: Dominique Baeten, 等
出版事項: (2015)

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
著者:: Jürgen Braun, 等
出版事項: (2005)

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
著者:: Jürgen Braun, 等
出版事項: (2011)

Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
著者:: Jürgen Braun, 等
出版事項: (2023)

Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study
著者:: Inman, Robert D., 等
出版事項: (2016)

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
著者:: Xenofon Baraliakos, 等
出版事項: (2023)

The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
著者:: Braun, Jürgen, 等
出版事項: (2014)

The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
著者:: Jürgen Braun, 等
出版事項: (2013)

The epidemiology of ankylosing spondylitis and the commencement of anti‐TNF therapy in daily rheumatology practice
著者:: Cruyssen, Bert Vander, 等
出版事項: (2007)

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
著者:: Bert Vander Cruyssen, 等
出版事項: (2007)

Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome
著者:: Annelies Boonen, 等
出版事項: (2009)

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
著者:: Braun, Jürgen, 等
出版事項: (2018)

The epidemiology of osteoporosis and fractures in ankylosing spondylitis
著者:: Sambrook, Philip N., 等
出版事項: (2012)

The epidemiology of osteoporosis and fractures in ankylosing spondylitis
著者:: Philip N. Sambrook, 等
出版事項: (2012)

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
著者:: Braun, Jürgen, 等
出版事項: (2011)

ASAS/EULAR recommendations for the management of ankylosing spondylitis
著者:: Zochling, J, 等
出版事項: (2006)

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
著者:: Désirée van der Heijde, 等
出版事項: (2022)

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
著者:: Ben A. C. Dijkmans, 等
出版事項: (2009)

Ankylosing spondylitis: an overview
著者:: Sieper, J, 等
出版事項: (2002)

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
著者:: Sudha Visvanathan, 等
出版事項: (2008)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
著者:: Braun, J, 等
出版事項: (2011)

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.
著者:: Jürgen Braun, 等
出版事項: (2002)

Definition of disease duration in ankylosing spondylitis: reassessing the concept
著者:: Davis, J C, 等
出版事項: (2006)

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis
著者:: Désirée van der Heijde, 等
出版事項: (2007)

Staging of patients with ankylosing spondylitis: a preliminary proposal
著者:: Braun, J, 等
出版事項: (2002)

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
著者:: Désirée van der Heijde, 等
出版事項: (2008)

Determinants of hyperkyphosis in patients with ankylosing spondylitis
著者:: Vosse, D, 等
出版事項: (2006)

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
著者:: Jürgen Braun, 等
出版事項: (2016)